Study investigator of Phase 1 trial presented poster at Society of Hematologic Oncology 13th annual conference highlighting original study protocol SOUTH SAN FRANSCISCO, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative cellular immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces it has administered a second dose in the second patient in th ...

A secure, U.S.-developed software and controls platform purpose-built for Eos Z3 battery systems to power and protect America’s energy future DawnOSTM will be offered to customers as part of a turnkey solution EDISON, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United S ...

SINGAPORE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for Bitcoin mining, today announced that it issued a notice of cleanup redemption for all $7,700,000 aggregate principal amount outstanding of its 8.50% convertible senior notes due 2029 (the "notes"). The cleanup redemption date will be September 23, 2025. The redemption price with respect to any redeemed note will equal 100% of the principal amount thereo ...

Boise, Idaho, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Idaho Copper Corp. (OTC: COPR), a critical minerals developer advancing a flagship copper-molybdenum project in Idaho, today announced the engagement of international investor relations specialists MZ Group (MZ) to lead a strategic investor relations and financial communications program across all key markets. MZ Group will work closely with Idaho Copper management to develop and implement a comprehensive capital markets strategy designed to increase the comp ...

Agreement to Serve as a Model for Future Collaborations to Create a National Network of TSDF Partnerships DURHAM, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) (“374Water”), a global leader in organic waste destruction technology and services for the municipal, federal, and industrial markets, today announced a Waste Destruction Services (“WDS”) collaboration agreement focused on PFAS eradication with Crystal Clean, a leading provider of environmental and waste management solutions t ...

Core Viewpoint - Birchtech Corp. has reached non-exclusive agreements with two affiliated coal-fired power utilities, resulting in the dismissal of claims against them in a patent litigation case regarding mercury emissions reduction technologies [1][3]. Group 1: Agreements and Legal Outcomes - The agreements include a one-time license fee and grant Birchtech the right to participate in the utilities' bidding processes for mercury emissions capture products over the next five years [2]. - As a result of these agreements, Birchtech has dismissed all claims against the two utilities and their parent company, while continuing claims against other non-affiliated defendants in the Iowa lawsuit [3]. Group 2: Business Strategy and Relationships - Birchtech's CEO highlighted the effectiveness of their "business-first" approach in building relationships with coal-fired power utilities since 2019, leading to the establishment of business relationships with four utilities involved in the ongoing lawsuits [4]. - The company has successfully reached 12 license and/or supply agreements with coal-fired utilities, including eight previously named as defendants in earlier lawsuits [5]. Group 3: Company Overview - Birchtech Corp. specializes in activated carbon technologies for air and water treatment, focusing on mercury emissions capture and developing technologies for water purification, particularly targeting forever chemicals like PFAS and PFOS [6].

New York, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on September 4, 2025, it caused to be deposited $0.15 per public share, totaling $10,890.15 (the “Extension Payment”) into its trust account (the “Trust Account”) with Continental Stock Transfer and Trust Company (“Continental”) to extend the deadline to complete its initial business combination from Septe ...

DURHAM, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today announced that Scott Plesha, CEO, and Frank Knuettel II, CFO, will participate in the upcoming September conferences: H.C. Wainwright 27th Annual Global Investment Conference and the Investor Summit Group Q3 Virtual Conference. Investor Conference Details: H.C ...

EB613 Demonstrates Significant Effects on Both Trabecular and Cortical Bone Compartments After Just 6 Months of Treatment in Phase 2 Study; Cortical Improvements Comparable to Injectable Teriparatide and Abaloparatide Company Plans to Initiate Global Registrational Phase 3 Study Following July 2025 FDA Concurrence Entera also Presented Promising Pharmacokinetic Data for Next-Gen EB613 Single Tablet Candidate as Potential Future Franchise Extension JERUSALEM, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Lt ...

Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the CompanyCHARLOTTE, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has completed the evaluation of strategic alternatives for its Wellspect Healthcare business (“Wellspect”), which was announced in February 2025. As a part of its review process, Dentsply Sirona considered a range of potential opportuni ...